ESC

A year of DOAC therapy did not result in significantly more bleeds in ONCO DVT trial

Pivotal trial "suggests the tantalizing possibility of genuine clinical improvement"

"Provocative" results for inorganic nitrate pill shown in NITRATE-CIN trial

Trial debunks strategy for higher-risk group

Phase II trial might not end the story for anti-inflammatory approach, though

MULTISTARS AMI trial helps answer the timing question in multivessel disease treatment

Lower bleeding risk of new blood thinners did not extend to this older subgroup

Trial in best-case scenario setting shows sending patients to specialty centers doesn't help

Novel catheters on par with thermal ablation, but do they meet the early high hopes?

Death and surgeries delayed in end-stage heart failure

BUDAPEST-CRT Upgrade is the first major trial on upgrade strategy

ECLS-SHOCK trial challenges current practice, guidelines

Trial affirms advantage over culprit-lesion-only stenting in those ages 75 and up

Hard endpoints do not favor IV ferric carboxymaltose in well-powered HEART-FID